Aterian, Inc. (NASDAQ:ATER – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 826,049 shares, an increase of 281.9% from the August 31st total of 216,312 shares. Approximately 10.3% of the company’s shares are short sold. Based on an average daily volume of 10,530,089 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
ATER has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aterian in a research report on Friday, August 14th. Wall Street Zen lowered shares of Aterian from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.
View Our Latest Analysis on ATER
Aterian Stock Down 1.6%
Aterian (NASDAQ:ATER – Get Free Report) last issued its earnings results on Friday, August 14th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.26). The firm had revenue of $0.01 million during the quarter, compared to the consensus estimate of $20.30 million. Aterian had a negative net margin of 49.30% and a negative return on equity of 92.04%.
Aterian Company Profile
Aterian, Inc is a technology-enabled consumer products company that develops, acquires, and sells products through online retail channels. The company uses data analytics, software, and automation to identify consumer needs, develop products, manage brands, and optimize marketing and distribution.
Aterian’s product portfolio has included goods for the home and kitchen, health and wellness, personal care, and other consumer categories. Its brands have included hOmeLabs, Mueller, Pursteam, Vremi, and Squatty Potty, although its portfolio may change as the company adds, expands, or divests brands.
See Also
- Five stocks we like better than Aterian
- 3 More AI Infrastructure Plays Beyond the Big Names
- CAVA Stock Slips: Sector Fear or Valuation Reality?
- Why Equal-Weight Funds Hide A Yield Curve Catch
- 5 Scary-Good Stocks With Strong October Catalysts and Breakout Potential
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
